Results 161 to 170 of about 10,634,853 (332)

Geography of Infectious Diseases

open access: yes, 2010
• The geography of many infections is dynamic. • Biological characteristics of organisms, human and animal host factors, and bioclimatic factors influence where diseases occur. • Diseases vary in their potential to be moved from one area to another. Those with a fixed focal distribution often require a specific arthropod vector or intermediate host ...
openaire   +3 more sources

Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to assess the efficacy and safety of using tocilizumab in children with febrile infection‐related epilepsy syndrome (FIRES) and explore tocilizumab‐related changes in interleukin (IL)‐6 levels. Methods Patients with FIRES admitted to the Intensive Care Unit (ICU) of Beijing Children's Hospital were retrospectively ...
Yushan He   +7 more
wiley   +1 more source

The Red Book is Coming to Town

open access: yesCanadian Journal of Infectious Diseases, 2003
Canadian Paediatric Society, Infectious Diseases and Immunization Committee
doaj   +1 more source

Clinical Characteristics of Parkinsonism in HTLV‐1‐Associated Myelopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the classic neurological manifestation of HTLV‐1 infection; however, this virus has also been associated with other neurological disorders. Concurrent parkinsonism is relatively rare and presents diagnostic challenges.
Mika Dozono   +8 more
wiley   +1 more source

Transfusion and Risk of Infection in Canada: UPDATE 2004

open access: yesCanadian Journal of Infectious Diseases, 2004
Canadian Paediatric Society, Infectious Diseases and Immunization Committee
doaj   +1 more source

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad   +8 more
wiley   +1 more source

Routine Immunization Schedule: Update 2004

open access: yesCanadian Journal of Infectious Diseases, 2004
Canadian Paediatric Society, Infectious Diseases and Immunization Committee
doaj   +1 more source

INFECTIOUS DISEASES [PDF]

open access: yesArchives of Internal Medicine, 1939
openaire   +1 more source

Infectious Diseases

open access: yesJournal of the Royal College of Physicians of London, 1991
R S, Heyderman, E, Larson
openaire   +2 more sources

Home - About - Disclaimer - Privacy